1
|
Chart-Pascual JP, Montero-Torres M, Ortega MA, Mar-Barrutia L, Zorrilla Martinez I, Alvarez-Mon M, Gonzalez-Pinto A, Alvarez-Mon MA. Areas of interest and sentiment analysis towards second generation antipsychotics, lithium and mood stabilizing anticonvulsants: Unsupervised analysis using Twitter. J Affect Disord 2024; 351:649-660. [PMID: 38290587 DOI: 10.1016/j.jad.2024.01.234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Revised: 01/23/2024] [Accepted: 01/26/2024] [Indexed: 02/01/2024]
Abstract
BACKGROUND Severe mental disorders like Schizophrenia and related psychotic disorders (SRD) or Bipolar Disorder (BD) require pharmacological treatment for relapse prevention and quality of life improvement. Yet, treatment adherence is a challenge, partly due to patients' attitudes and beliefs towards their medication. Social media listening offers insights into patient experiences and preferences, particularly in severe mental disorders. METHODS All tweets posted between 2008 and 2022 mentioning the names of the main drugs used in SRD and BD were analyzed using advanced artificial intelligence techniques such as machine learning, and deep learning, along with natural language processing. RESULTS In this 15-year study analyzing 893,289 tweets, second generation antipsychotics received more mentions in English tweets, whereas mood stabilizers received more tweets in Spanish. English tweets about economic and legal aspects displayed negative emotions, while Spanish tweets seeking advice showed surprise. Moreover, a recurring theme in Spanish tweets was the shortage of medications, evoking feelings of anger among users. LIMITATIONS This study's analysis of Twitter data, while insightful, may not fully capture the nuances of discussions due to the platform's brevity. Additionally, the wide therapeutic use of the studied drugs, complicates the isolation of disorder-specific discourse. Only English and Spanish tweets were examined, limiting the cultural breadth of the findings. CONCLUSION This study emphasizes the importance of social media research in understanding user perceptions of SRD and BD treatments. The results provide valuable insights for clinicians when considering how patients and the general public view and communicate about these treatments in the digital environment.
Collapse
Affiliation(s)
- Juan Pablo Chart-Pascual
- Psychiatry Department, Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain; University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain; CIBERSAM.
| | - Maria Montero-Torres
- Ramón y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain; Department of Medicine and Medical Specialities, University of Alcala, 28801 Alcala de Henares, Madrid, Spain
| | - Miguel Angel Ortega
- Cancer Registry and Pathology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain; Ramón y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain; Department of Medicine and Medical Specialities, University of Alcala, 28801 Alcala de Henares, Madrid, Spain
| | - Lorea Mar-Barrutia
- Psychiatry Department, Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain; CIBERSAM
| | - Iñaki Zorrilla Martinez
- Psychiatry Department, Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain; University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain; CIBERSAM
| | - Melchor Alvarez-Mon
- Immune System Diseases-Rheumatology and Internal Medicine Service, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas, University Hospital Príncipe de Asturias, Alcala de Henares, Spain; Ramón y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain; Department of Medicine and Medical Specialities, University of Alcala, 28801 Alcala de Henares, Madrid, Spain
| | - Ana Gonzalez-Pinto
- Psychiatry Department, Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain; University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain; CIBERSAM
| | - Miguel Angel Alvarez-Mon
- Ramón y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain; Department of Medicine and Medical Specialities, University of Alcala, 28801 Alcala de Henares, Madrid, Spain; Department of Psychiatry and Mental Health, Hospital Universitario Infanta Leonor, Madrid, Spain
| |
Collapse
|
2
|
Couderc S, Djerada Z, Rivals F, Lemaire-Hurtel AS, Lelong-Boulouard V, Lelièvre B, Abbara C, Lafay C, Abe E, Libert F, Pressiat C, Montange D, Imbert L, Tonini J, Lenski M, Guilhaumou R, Mathieu O. Questionnaire about therapeutic drug monitoring (TDM) of psychotropics for a panel of French psychiatrists. Therapie 2024:S0040-5957(24)00008-8. [PMID: 38355346 DOI: 10.1016/j.therap.2024.01.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Revised: 01/05/2024] [Accepted: 01/25/2024] [Indexed: 02/16/2024]
Affiliation(s)
- Sylvain Couderc
- Department of Pharmacology and Toxicology, University Hospital, 87000 Limoges, France.
| | - Zoubir Djerada
- Department of Pharmacology and Toxicology, University Hospital, 51092 Reims, France
| | - Florence Rivals
- Department of Pharmacology and Toxicology, University Hospital, 87000 Limoges, France
| | | | | | - Bénédicte Lelièvre
- Department of Pharmacology and Toxicology, University Hospital, 49100 Angers, France
| | - Chadi Abbara
- Department of Pharmacology and Toxicology, University Hospital, 49100 Angers, France
| | - Claire Lafay
- Department of Pharmacology and Toxicology, University Hospital, 86000 Poitiers, France
| | - Emuri Abe
- Department of Pharmacology and Toxicology, University Hospital, Raymond Poincare Hospital, AP-HP, 92380 Garches, France
| | - Frédéric Libert
- Department of Pharmacology, University Hospital, 63000 Clermont-Ferrand, France
| | - Claire Pressiat
- Department of Pharmacology, University Hospital, Henri-Mondor Hospital, AP-HP, 94010 Créteil, France
| | - Damien Montange
- Department of Pharmacology and Toxicology, University Hospital, 25030 Besançon, France
| | - Laurent Imbert
- Department of Pharmacology and Toxicology, University Hospital, 76000 Rouen, France
| | - Julia Tonini
- Department of Pharmacology and Toxicology, University Hospital, 38000 Grenoble, France
| | - Marie Lenski
- Department of Toxicology, University hospital, 59045 Lille, France
| | - Romain Guilhaumou
- Department of Pharmacology, University Hospital, La Timone Hospital, AP-HM, 13005 Marseille, France
| | - Olivier Mathieu
- Department of Pharmacology and Toxicology, University Hospital, 34090 Montpellier, France
| |
Collapse
|
3
|
Nielsen RE, Licht RW. The true effect of lithium is hard to determine. BJPsych Open 2023; 9:e187. [PMID: 37822221 PMCID: PMC10594167 DOI: 10.1192/bjo.2023.572] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/21/2023] [Revised: 08/21/2023] [Accepted: 08/25/2023] [Indexed: 10/13/2023] Open
Abstract
Lithium is the primary choice for preventing bipolar disorder relapses, endorsed by guidelines. A recent systematic review by Ulrichsen et al. showed limitations in assessing its specific impact, but data supports lithium's effectiveness in managing symptoms and preventing relapse. Comprehensive guidelines and research are crucial for its continued use.
Collapse
Affiliation(s)
- René Ernst Nielsen
- Department of Psychiatry, Aalborg University Hospital, Denmark; and Department of Clinical Medicine, Aalborg University, Denmark
| | - Rasmus W. Licht
- Department of Psychiatry, Aalborg University Hospital, Denmark; and Department of Clinical Medicine, Aalborg University, Denmark
| |
Collapse
|